Immunoglobulin sub-class distribution in bipolar disorder and schizophrenia: Potential relationship with latent Toxoplasma Gondii infection

BMC Psychiatry

Volumn 18, Issue 1, 2018, Pages

  Hamdani, Nora ^a,b,c   Bengoufa, Djaouida ^f   Godin, Ophélia ^a,c   Doukhan, Raphaël ^b   Le Guen, Emmanuel ^a,b   Daban Huard, Claire ^a,b,c   Bennabi, Meriem ^f   Delavest, Marine ^e   Lépine, Jean Pierre ^e   Boukouaci, Wahid ^f   Laouamri, Hakim ^c   Houenou, Josselin ^a,b,c,d   Jamain, Stéphane ^a,c   Richard, Jean Romain ^a,c   Lecorvosier, Philippe ^b   Yolken, Robert ^g   Rajagopal, Krishnamoorthy ^c   Leboyer, Marion ^a,b,c   Tamouza, Ryad ^c,f  

^a INSERM U955   (France)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^c FONDATION FONDAMENTAL   (France)

^d NeuroSpin   (France)

^e HÔPITAL FERNAND WIDAL   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bipolar disorder; Humoral immunity; Immunoglobulins; Schizophrenia; Toxoplasma gondii

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M;

ADULT; ANTIBODY DETECTION; ARTICLE; BIPOLAR DISORDER; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HOSPITALIZATION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOTURBIDIMETRY; LATENT TOXOPLASMOSIS; MAJOR CLINICAL STUDY; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; POSITIVE AND NEGATIVE SYNDROME SCALE; RISK FACTOR; SCHIZOPHRENIA; BLOOD; CASE CONTROL STUDY; COMPLICATION; IMMUNOLOGY; MIDDLE AGED; PARASITOLOGY; TOXOPLASMA; TOXOPLASMOSIS; YOUNG ADULT;

ADULT; BIPOLAR DISORDER; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOGLOBULINS; MALE; MIDDLE AGED; RISK FACTORS; SCHIZOPHRENIA; TOXOPLASMA; TOXOPLASMOSIS; YOUNG ADULT;

EID: 85050679052     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/s12888-018-1821-9     Document Type: Article

References (38)

1. Amkraut A, Solomon GF, Allansmith M, McClellan B, Rappaport M. Immunoglobulins and improvement in acute schizophrenic reactions. Arch Gen Psychiatry. 1973;28(5):673-7.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorderscity, state: publisher. Manual of Mental Disorders, 4th edition. Washington, DC: Author; 1994.
3. Bălăiţă C, Iscrulescu C, Sârbulescu A. Serum immunoglobulin levels in schizoaffective disorders (manic and depressive). Rom J Neurol Psychiatry. 1992;30(1):63-71.
4. Buka SL, Cannon TD, Torrey EF, Yolken RH. Collaborative study group on the perinatal origins of severe psychiatric disorders. Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring. Biol Psychiatry. 2008;63(8):809-15.
5. Brown AS. Exposure to prenatal infection and risk of schizophrenia. Front Psychiatry. 2011;2:63.
6. Chong-Thim W, Wing-Foo T, Nilmani S. Serum immunoglobulin levels in Chinese male schizophrenics. Schizophr Res. 1993;10(1):61-6.
7. Dickerson FB, Boronow JJ, Stallings C, Origoni AE, Ruslanova I, Yolken RH. Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia. Arch Gen Psychiatry. 2003;60(5):466-72.
8. Dickerson FB, Boronow JJ, Stallings C, Origoni AE, Cole S, Krivogorsky B, Yolken RH. Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder. Biol Psychiatry. 2004;55(6):588-93.
9. Dickerson F, Boronow J, Stallings C, Origoni A, Yolken R. Toxoplasma gondii in individuals with schizophrenia: association with clinical and demographic factors and with mortality. Schizophr Bull. 2007;33(3):737-40.
10. Gowdy JM. Immunoglobulin levels in psychotic patients. Psychosomatics. 1980;21(9):751-6.
11. Fontana A, Storck U, Angst J, Dubs R, Abegg A, Grob PJ. An immunological basis of schizophrenia and affective disorders? Neuropsychobiology. 1980;6(5):284-9.
12. Hamdani N, Daban-Huard C, Lajnef M, et al. Relationship between toxoplasma gondii infection and bipolar disorder in a French sample. J Affect Disord. 2013;148(2-3):444-8.
13. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Br J Addict. 1991;86(9):1119-27.
14. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261-76.
15. Legros S, Mendlewicz J, Wybran J. Immunoglobulins, autoantibodies and other serum protein fractions in psychiatric disorders. Eur Arch Psychiatry Neurol Sci. 1985;235(1):9-11.
16. Lo L-H, Shiea J, Huang T-L. Rapid detect ion of alteration of serum IgG in patients with schizophrenia after risperidone treatment by matrix-assisted laser desorption ionization/ time-of-flight mass spectrometry. Rapid Commun Mass Spectrom. 2016;30:2645-9.
17. Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry. 2011;70(7):663-71.
18. Montgomery SA, Asberg MA. New depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134(4):382-9.
19. Mortensen PB, Pedersen CB, Hougaard DM, Nørgaard-Petersen B, Mors O, Børglum AD, Yolken RH. A Danish National Birth Cohort study of maternal HSV-2 antibodies as a risk factor for schizophrenia in their offspring. Schizophr Res. 2010;122(1-3):257-63.
20. Muller N, Schwarz M. Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission. Neurotox Res. 2006;10(2):131-48.
21. Müller N, Weidinger E, Leitner B, Schwarz MJ. The role of inflammation in schizophrenia. Front Neurosci. 2015; 21; 9:372.
22. Muneer A. Bipolar disorder: role of inflammation and the development of disease biomarkers. Psychiatry Investig. 2016;13(1):18-33.
23. Niebuhr DW, Millikan AM, Cowan DN, Yolken R, Li Y, Weber NS. Selected infectious agents and risk of schizophrenia among U.S. military personnel. Am J Psychiatry. 2008;165(1):99-106.
24. NIMH. Genetics initiative: family interview for genetic studies (FIGS). National Institute of Mental Health: Rockville; 1992.
25. Nurnberger JI, Blehar MC, Kaufmann CA, et al. Diagnostic Interview for Genetic Studies (DIGS). Archives General Psychiatry. 1994;51:849-59.
26. Nurnberger JI Jr, Blehar MC, Kaufmann CA York-Cooler C, Simpson SG, Harkavy-Friedman J, et al. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch General Psychiatr 1994;5:849-64.
27. Pulkkinen E. Immunoglobulins, psychopathology and prognosis in schizophrenia. Acta Psychiatr Scand. 1977;56(3):173-82.
28. Rosenblat JD, McIntyre RS. Bipolar disorder and inflammation. Psychiatr Clin North Am. 2016;39(1):125-37.
29. Sane AS, Chawla MS, Chokshi SA, Mathur V, Barad DP, Shah VC, Patel MJ. Serum immunoglobulin status of psychiatric in-patients. Panminerva Med. 1990;32(2):88-91.
30. Corp S. Stats statistical software: release 13. College Station: StataCorp LP; 2013.
31. Sutterland AL, Fond G, Kuin A, Koeter MW, Lutter R, van Gool T, Yolken R, Szoke A, Leboyer, M, de Haan L. Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis. Acta Psychiatr Scand 2015; 132(3):161-179.
32. Tiwari SG, Lal N, Trivedi JK, Sayeed J, Bahauguna LM. Immunoglobulin patterns in schizophrenic patients. Indian J Psychiatry. 1984;26(3):223-8.
33. Toorey EF, Peterson MR, Brannon WL, Carpenter WT, Post RM, Van Kammen DP. Immunoglobulins and viral antibodies in psychiatric patients. Br J Psychiatry. 1978;132:342-8.
34. Tudorache B, Bălăiţă C, Christodorescu D. Serum immunoglobulin (a, G, M) levels in primary bipolar affective disorders. Rom J Neurol Psychiatry. 1991;29(1-2):35-51.
35. Wadee AA, Kuschke RH, Wood LA, Berk M, Ichim L, Maes M. Serological observations in patients suffering from acute manic episodes. Hum Psychopharmacol. 2002;17(4):175-9.
36. Yolken RH, Torrey EF. Viruses, schizophrenia, and bipolar disorder. Clin Microbiol Rev. 1995;8(1):131-45.
37. Yolken R, Torrey EF, Dickerson F. Evidence of increased exposure to toxoplasma gondii in individuals with recent onset psychosis but not with established schizophrenia. PLoS Negl Trop Dis. 2017;11(11):e0006040.
38. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133(5):429-35.